These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31507532)

  • 21. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone.
    De Placido G; Alviggi C; Mollo A; Strina I; Varricchio MT; Molis M
    Hum Reprod; 2000 Jan; 15(1):17-20. PubMed ID: 10611181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-free 3D culture supports human follicular development from the unilaminar to the antral stage in vitro yielding morphologically normal metaphase II oocytes.
    Xu F; Lawson MS; Bean Y; Ting AY; Pejovic T; De Geest K; Moffitt M; Mitalipov SM; Xu J
    Hum Reprod; 2021 Apr; 36(5):1326-1338. PubMed ID: 33681988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review.
    Trew GH; Brown AP; Gillard S; Blackmore S; Clewlow C; O'Donohoe P; Wasiak R
    Reprod Biol Endocrinol; 2010 Nov; 8():137. PubMed ID: 21059191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfa.
    Griesinger G; Teal V; McCrary Sisk C; Ruman J
    Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():101-105. PubMed ID: 30529793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing a combined stimulation protocol hFSH followed by rFSH might represent a breakthrough in the IVF practice.
    Gerli S; Di Renzo GC
    Eur Rev Med Pharmacol Sci; 2013; 17(15):2091-6. PubMed ID: 23884831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of urinary and recombinant gonadotropins on in vitro maturation outcomes of mouse preantral follicles.
    Park KE; Ku SY; Jung KC; Liu HC; Kim YY; Kim YJ; Kim SH; Choi YM; Kim JG; Moon SY
    Reprod Sci; 2013 Aug; 20(8):909-16. PubMed ID: 23239820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
    Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous administration of human acidic and recombinant less acidic follicle-stimulating hormone for ovarian stimulation improves oocyte and embryo quality, and clinical outcome in patients with repeated IVF failures.
    Selman H; Pacchiarotti A; Rinaldi L; Crescenzi F; Lanzilotti G; Lofino S; El-Danasouri I
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1814-9. PubMed ID: 23852909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streamlining follicular monitoring during controlled ovarian stimulation: a data-driven approach to efficient IVF care in the new era of social distancing.
    Robertson I; Chmiel FP; Cheong Y
    Hum Reprod; 2021 Jan; 36(1):99-106. PubMed ID: 33147345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.
    Lai Q; Chen C; Zhang Z; Zhang S; Yu Q; Yang P; Hu J; Wang CY
    Int J Clin Exp Pathol; 2013; 6(2):258-66. PubMed ID: 23330011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
    Polyzos NP; Neves AR; Drakopoulos P; Spits C; Alvaro Mercadal B; Garcia S; Ma PQM; Le LH; Ho MT; Mertens J; Stoop D; Tournaye H; Vuong NL
    Hum Reprod; 2021 May; 36(6):1711-1721. PubMed ID: 33889959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin promotes development and function of macaque primary follicles during encapsulated three-dimensional culture.
    Xu J; Lawson MS; Yeoman RR; Molskness TA; Ting AY; Stouffer RL; Zelinski MB
    Hum Reprod; 2013 Aug; 28(8):2187-200. PubMed ID: 23608357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy.
    Mannaerts BM; Rombout F; Out HJ; Coelingh Bennink H
    Hum Reprod Update; 1996; 2(2):153-61. PubMed ID: 9079410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.